Multiple Testing of Noninferiority Hypotheses in Active Controlled Trials

References

• Blackwelder , W. C. 1982 . “Proving the Null Hypothesis” in clinical trials . Controlled Clin. Trials , 3 : 345 – 353 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Committee for Proprietary Medicinal Products (CPMP). Points to consider on switching between superiority and non-inferiority 2000. http://www.eudra. org/emea.html
   Google Scholar
• Dunnett , C. W. and Gent , M. 1977 . Significance testing to establish equivalence between treatments, with special reference to data in the form of 2 × 2 Tables . Biometrics , 3 : 593 – 602 .
   Google Scholar
• Dunnett , C. W. and Tamhane , A. C. 1997 . Multiple testing to establish superiority/equivalence of a new treatment compared with kappa standard treatments . Statist. Med. , 16 ( 21 ) : 2489 – 2506 . [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ebbutt , A. F. and Frith , L. 1998 . Practical issues in equivalence trials . Statist. Med. , 17 : 1691 – 1701 . [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ellenberg , S. S. and Temple , R. 2000 . Placebo-controlled trials and active-control trials in the evaluation of new treatments – Part 2: Practical issues and specific cases . Ann. Internal Med. , 133 : 464 – 470 . [CSA]
   PubMed Web of Science ®Google Scholar
• Fisher , L. D. , Gent , M. and Bηller , H. R. 2001 . Active-control trials: How would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo . Amer. Heart J. , 141 : 26 – 32 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fleming , T. R. 1987 . Treatment evaluation in active control studies . Cancer Treatment Rep. , 71 : 1061 – 1064 . [CSA]
   PubMedGoogle Scholar
• Fleming , T. R. 1990 . Evaluation of active control trials in AIDS . J. Acquired Immune Deficiency Syndromes , 3 ( Suppl. 2 ) : S82 – S87 .
   PubMed Web of Science ®Google Scholar
• Gould , A. L. 1991 . Another view of active-controlled trials . Controlled Clin. Trials , 12 : 474 – 485 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMedGoogle Scholar
• Hasselblad , V. and Kong , D. F. 2001 . Statistical methods for comparison to placebo in active-control trials . Drug Inf. J. , 35 : 435 – 449 .
   Web of Science ®Google Scholar
• Holmgren , E. B. 1999 . Establishing equivalence by showing that a prespecified percentage of the effect of the active control over placebo is maintained . J. Biopharmaceutical Statist. , 9 ( 4 ) : 651 – 659 . [CSA] [CROSSREF]
   PubMedGoogle Scholar
• Hung , H. M. J. , Wang , S. J. , Tsong , Y. , Lawrence , J. and O'Neill , R. 2003 . Some fundamental issues with non-inferiority testing in active controlled trials . Statist. Med. , 22 ( 2 ) : 213 – 225 . [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Morikawa , T. and Yoshida , M. 1995 . A useful testing strategy in phase III trials: Combined test of superiority and test of equivalence . J. Biopharmaceutical Statist. , 5 ( 3 ) : 297 – 306 . [CSA]
   PubMedGoogle Scholar
• Rohmel , J. 1998 . Therapeutic equivalence investigations: Statistical considerations . Statist. Med. , 17 : 1703 – 1714 . [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rothmann , M. , Li , N. , Chen , G. , Chi , G. Y. H. and Tsou , H. H. 2003 . Design and analysis of non-inferiority mortality trials in oncology . Statist. Med. , 22 ( 2 ) : 239 – 264 . [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Simon , R. 1999 . Bayesian design and analysis of active control clinical trials . Biometrics , 55 : 484 – 487 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Temple , R. 1983 . Difficulties in evaluating positive control trials. In: Proceedings of the Biopharmaceutical Section of the American Statistical Association, American Statistical Association, Alexandria, VA, USA, pp. 48–54
   Google Scholar
• Temple , R. 1996 . Problems in interpreting active control equivalence trials . Accountability Res. , 4 : 267 – 275 . [CSA]
   PubMedGoogle Scholar
• Temple , R. and Ellenberg , S. S. 2000 . Placebo-controlled trials and active-control trials in the evaluation of new treatments – Part 1: Ethical and scientific issues . Ann. Internal Med. , 133 : 455 – 463 . [CSA]
   PubMed Web of Science ®Google Scholar
• Tsong , Y , Wang , S. J. , Hung , H. M. J. and Cui , L. 2003 . Statistical issues on objective, design and analysis of non-inferiority active controlled clinical trial . J. Biopharmaceutical Statist. , 13 ( 1 ) : 29 – 42 . [CSA] [CROSSREF]
   PubMedGoogle Scholar
• Wang , S. J. and Hung , H. M. J. 2003 . Assessing treatment efficacy in non-inferiority trial . Controlled Clin. Trials , 24 ( 2 ) : 147 – 155 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMedGoogle Scholar
• Wang , S. J. , Hung , H. M. J. , Tsong , Y. , Cui , L. and Nuri , W. A. 1997 . Changing the study objective in clinical trials. In: Proceedings of the Biopharmaceutical Section of the American Statistical Association, American Statistical Association, Alexandria, VA, USA, pp. 64–69
   Google Scholar
• Wang , S. J. , Hung , H. M. J. , Tsong , Y. and Cui , L. 2001 . Group sequential testing for superiority and non-inferiority hypotheses in active controlled clinical trials . Statist. Med. , 20 : 1903 – 1912 . [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wang , S. J. , Hung , H. M. J. and Tsong , Y. 2002 . Utility and pitfall of some statistical methods in active controlled clinical trials . Controlled Clin. Trials , 23 : 15 – 28 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMedGoogle Scholar
• #The opinions expressed are those of the authors and not necessarily those of the US Food and Drug Administration.
   Google Scholar